Search Results

There are 1434 results for: content related to: Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans

  1. You have free access to this content
    H1-antihistamines for chronic spontaneous urticaria

    Intervention Review

    The Cochrane Library

    Maulina Sharma, Cathy Bennett, Stuart N Cohen and Ben Carter

    Published Online : 14 NOV 2014, DOI: 10.1002/14651858.CD006137.pub2

  2. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms

    Clinical & Experimental Allergy

    Volume 38, Issue 6, June 2008, Pages: 947–956, C. Roumestan, C. Henriquet, C. Gougat, A. Michel, F. Bichon, K. Portet, D. Jaffuel and M. Mathieu

    Version of Record online : 22 MAY 2008, DOI: 10.1111/j.1365-2222.2008.02990.x

  3. Oral Abstract Session 1 — Allergens


    Volume 54, Issue s68, August 2000, Pages: 1–281,

    Version of Record online : 30 APR 2008, DOI: 10.1111/j.1398-9995.2000.tb04732.x

  4. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?

    Clinical & Experimental Allergy

    Volume 37, Issue 3, March 2007, Pages: 400–414, P. Devillier and J. Bousquet

    Version of Record online : 9 MAR 2007, DOI: 10.1111/j.1365-2222.2007.02662.x

  5. Pharmacological profile of the new antihistamines

    Clinical & Experimental Allergy Reviews

    Volume 5, Issue 1, July 2005, Pages: 7–11, J.-P. Tillement

    Version of Record online : 22 JUN 2005, DOI: 10.1111/j.1365-2222.2005.0075.x

  6. One-year treatment of chronic urticaria with mizolastine: efficacy and safety

    Journal of the European Academy of Dermatology and Venereology

    Volume 14, Issue 2, March 2000, Pages: 83–90, G Lorette, A Giannetti, Rs Pereira, F Leynadier, M Murrieta-Aguttes and the URTOL study group

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1468-3083.2000.00014.x

  7. Other topics


    Volume 55, Issue s63, July 2000, Pages: 239–282,

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1398-9995.2000.tb04540.x

  8. Differential modulation of mediator release from human basophils and mast cells by mizolastine

    Clinical & Experimental Allergy

    Volume 34, Issue 2, February 2004, Pages: 241–249, M. Triggiani, G. Giannattasio, B. Balestrieri, F. Granata, M. H. Gelb, A. De Paulis and G. Marone

    Version of Record online : 27 FEB 2004, DOI: 10.1111/j.1365-2222.2004.01851.x

  9. Influence of mizolastine on antigen-induced activation of signalling pathways in murine mast cells

    Clinical and Experimental Dermatology

    Volume 31, Issue 2, March 2006, Pages: 260–265, Q. Xia, W. M. Zhou, S. Yang, S. Q. Zhang, B. Chen, D. B. Wang, Y. Wang and X. J. Zhang

    Version of Record online : 8 FEB 2006, DOI: 10.1111/j.1365-2230.2006.02050.x

  10. Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue 5, May 2015, Pages: 419–428, Christian Termeer, Petra Staubach, Hjalmar Kurzen, Klaus Strömer, Rolf Ostendorf and Marcus Maurer

    Version of Record online : 27 APR 2015, DOI: 10.1111/ddg.12633

  11. Clinical advantages of dual activity in allergic rhinitis


    Volume 55, Issue s64, December 2000, Pages: 34–39, F. Horak

    Version of Record online : 2 JAN 2002, DOI: 10.1034/j.1398-9995.2000.00805.x

  12. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 206–211, M. C. Delauche-Cavallier, S. Chaufour, E. Guérault, A. Lacroux, M. Murrieta and A. Wajman

    Version of Record online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3206.x

  13. Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios

    Human Psychopharmacology: Clinical and Experimental

    Volume 23, Issue 7, October 2008, Pages: 555–570, Kathleen McDonald, Leanne Trick and Julia Boyle

    Version of Record online : 11 JUL 2008, DOI: 10.1002/hup.962

  14. You have free access to this content
    Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

    British Journal of Clinical Pharmacology

    Volume 39, Issue 1, January 1995, Pages: 31–38, A Patat, MC Perault, B Vandel, N Ulliac, I Zieleniuk and P Rosenzweig

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1995.tb04406.x

  15. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis


    Volume 53, Issue 10, October 1998, Pages: 969–975, C. Bachert, J. Brostoff, G. K. Scadding, J. Tasman, A. Stalla-Bourdillon, M. Murrieta and RIPERAN Study Group

    Version of Record online : 29 APR 2007, DOI: 10.1111/j.1398-9995.1998.tb03798.x

  16. Lack of subsensitivitvy to mizolastine over 8-week treatment


    Volume 51, Issue 4, April 1996, Pages: 251–256, J. Bousquet, I. Chanal, M. Murrieta and A. Stalla-Bourdillon

    Version of Record online : 29 APR 2007, DOI: 10.1111/j.1398-9995.1996.tb04601.x

  17. Clinical advantages of dual activity in urticaria


    Volume 55, Issue s64, December 2000, Pages: 28–33, K. Kontou-Fili

    Version of Record online : 2 JAN 2002, DOI: 10.1034/j.1398-9995.2000.00804.x

  18. You have free access to this content
    Allergic Rhinitis and its Impact on Asthma (ARIA) 2008


    Volume 63, Issue s86, April 2008, Pages: 8–160, J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens, A. Togias, T. Zuberbier, C. E. Baena-Cagnani, G. W. Canonica, C. Van Weel, I. Agache, N. Aït-Khaled, C. Bachert, M. S. Blaiss, S. Bonini, L.-P. Boulet, P.-J. Bousquet, P. Camargos, K.-H. Carlsen, Y. Chen, A. Custovic, R. Dahl, P. Demoly, H. Douagui, S. R. Durham, R. Gerth Van Wijk, O. Kalayci, M. A. Kaliner, Y.-Y. Kim, M. L. Kowalski, P. Kuna, L. T. T. Le, C. Lemiere, J. Li, R. F. Lockey, S. Mavale-Manuel, E. O. Meltzer, Y. Mohammad, J. Mullol, R. Naclerio, R. E. O’Hehir, K. Ohta, S. Ouedraogo, S. Palkonen, N. Papadopoulos, G. Passalacqua, R. Pawankar, T. A. Popov, K. F. Rabe, J. Rosado-Pinto, G. K. Scadding, F. E. R. Simons, E. Toskala, E. Valovirta, P. Van Cauwenberge, D.-Y. Wang, M. Wickman, B. P. Yawn, A. Yorgancioglu, O. M. Yusuf, H. Zar, I. Annesi-Maesano, E. D. Bateman, A. Ben Kheder, D. A. Boakye, J. Bouchard, P. Burney, W. W. Busse, M. Chan-Yeung, N. H. Chavannes, A. Chuchalin, W. K. Dolen, R. Emuzyte, L. Grouse, M. Humbert, C. Jackson, S. L. Johnston, P. K. Keith, J. P. Kemp, J.-M. Klossek, D. Larenas-Linnemann, B. Lipworth, J.-L. Malo, G. D. Marshall, C. Naspitz, K. Nekam, B. Niggemann, E. Nizankowska-Mogilnicka, Y. Okamoto, M. P. Orru, P. Potter, D. Price, S. W. Stoloff, O. Vandenplas, G. Viegi and D. Williams

    Version of Record online : 7 MAR 2008, DOI: 10.1111/j.1398-9995.2007.01620.x

  19. You have free access to this content
    Inhibition of HERG1 K+ channels by the novel second-generation antihistamine mizolastine

    British Journal of Pharmacology

    Volume 131, Issue 6, November 2000, Pages: 1081–1088, Maurizio Taglialatela, Anna Pannaccione, Pasqualina Castaldo, Giovanna Giorgio and Lucio Annunziato

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703654

  20. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria


    Volume 51, Issue 5, May 1996, Pages: 320–325, J. Brostoff, P. Fitzharris, C. Dunmore, M. Theron and P. Blondin

    Version of Record online : 29 APR 2007, DOI: 10.1111/j.1398-9995.1996.tb04616.x